Labor & Human Resources
Executive Summary
At a markup scheduled for Aug. 1, committee will look at Chairman Kennedy's (D-Mass.) S 2649, a bill designed to encourage development of drug abuse treatments by offering such therapies seven years of market exclusivity in a provision modeled on the Orphan Drug Act ("The Pink Sheet" June 4, T&G-3). The bill would require HHS to look at advertising and marketing of legal drugs in the context of determining if a correlation exists between consumption of legal and illegal drugs.